Nektar Therapeutics (NKTR)
37.80
+0.54
(+1.45%)
USD |
NASDAQ |
Nov 09, 16:00
37.80
0.00 (0.00%)
After-Hours: 17:49
Nektar Therapeutics Gross Profit (Annual) : 54.21M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 54.21M |
| December 31, 2024 | 66.47M |
| December 31, 2023 | 53.48M |
| December 31, 2022 | 62.92M |
| December 31, 2021 | 67.19M |
| December 31, 2020 | 124.18M |
| December 31, 2019 | 85.10M |
| December 31, 2018 | 1.163B |
| December 31, 2017 | 270.19M |
| December 31, 2016 | 127.27M |
| December 31, 2015 | 190.16M |
| December 31, 2014 | 165.54M |
| December 31, 2013 | 102.87M |
| December 31, 2012 | 50.76M |
| December 31, 2011 | 49.59M |
| December 31, 2010 | 133.37M |
| Date | Value |
|---|---|
| December 31, 2009 | 40.98M |
| December 31, 2008 | 56.52M |
| December 31, 2007 | 125.54M |
| December 31, 2006 | 95.59M |
| December 31, 2005 | 86.08M |
| December 31, 2004 | 90.55M |
| December 31, 2003 | 87.36M |
| December 31, 2002 | 69.40M |
| December 31, 2001 | 35.16M |
| December 31, 2000 | 0.00 |
| December 31, 1999 | 0.00 |
| December 31, 1998 | 0.00 |
| December 31, 1997 | 0.00 |
| December 31, 1996 | 0.00 |
| December 31, 1995 | 0.00 |
| December 31, 1994 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Eli Lilly & Co. | 54.13B |
| Inovio Pharmaceuticals, Inc. | -2.924M |
| Tonix Pharmaceuticals Holding Corp. | 4.542M |
| Capricor Therapeutics, Inc. | -1.890M |
| ADMA Biologics, Inc. | 292.62M |